2020 - Affluent Medical


Affluent Medical’s capital strengthening with private placements worth €10.3 million and €4.1 million respectively.


Kephalios and Epygon receive €2.3 million in grants and repayable advances from THE PSPC Mivana project with the completion of new milestones.


Launch of the Minerva pilot clinical study of the Epygon medical device with the approval of the Austrian competent Authority.


Management team strengthening with the recruitment of Olivier Pierron as Chief Operating Officer and Jérôme Geoffroy as Chief Financial Officer.